SuperworthTraws Pharma EPS TRAW
Diluted earnings per share by quarter and over the last twelve months, from 2012.
- Last 12 months, to Jun 30, 2026
- −$1.61
- Latest quarter, Q2 FY26
- −$0.16
- Fiscal year 2025
- $1.06
Traws Pharma's earnings per share was −$1.61 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.16.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $1.06 | n/a |
| FY2024 | −$34.91 | n/a |
| FY2023 | −$22.62 | n/a |
| FY2022 | −$22.75 | n/a |
| FY2021 | −$24.75 | n/a |
| FY2020 | −$53.50 | n/a |
| FY2019 | −$1046.25 | n/a |
| FY2018 | −$3030.00 | n/a |
| FY2017 | −$15903.75 | n/a |
| FY2016 | −$32118.75 | n/a |
| FY2015 | −$62718.75 | n/a |
| FY2014 | −$165937.50 | n/a |
| FY2013 | −$748687.50 | n/a |
| FY2012 | −$859500.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.16 | n/a | −$1.61 | |
| Q1 FY26 | −$0.53 | −125% | −$1.56 | |
| Q4 FY25 | −$0.58 | n/a | $1.06 | |
| Q3 FY25 | −$0.34 | n/a | −$5.34 | |
| Q2 FY25 | −$0.11 | n/a | −$6.49 | |
| Q1 FY25 | $2.09 | n/a | −$26.90 | |
| Q4 FY24 | −$6.98 | n/a | −$34.91 | |
| Q3 FY24 | −$1.49 | n/a | −$32.91 | |
| Q2 FY24 | −$20.52 | n/a | −$37.06 | |
| Q1 FY24 | −$5.92 | n/a | −$21.54 | |
| Q4 FY23 | −$4.98 | n/a | −$22.62 | |
| Q3 FY23 | −$5.64 | n/a | −$24.14 |
Against its peers
Companies in Healthcare nearest Traws Pharma's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| TRAWTraws Pharma | −$1.61 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Traws Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.